NUVECTIS PHARMA INC's ticker is and the CUSIP is 67080T108. A total of 34 filers reported holding NUVECTIS PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BALDWIN BROTHERS LLC/MA | 116,380 | $1,500,138 | 0.13% |
| FORBES J M & CO LLP | 34,000 | $438,260 | 0.06% |
| Moran Wealth Management, LLC | 16,697 | $215,224 | 0.01% |
| Dorsey Wright & Associates | 1,396 | $17,994 | 0.01% |
| Tower Research Capital LLC (TRC) | 7,282 | $93,865 | 0.00% |
| MARSHALL WACE, LLP | 36,085 | $465,136 | 0.00% |
| Renaissance Technologies | 25,400 | $327 | 0.00% |
| UBS Group AG | 3,776 | $48,672 | 0.00% |
| RHUMBLINE ADVISERS | 7,273 | $93,742 | 0.00% |
| HOLLENCREST CAPITAL MANAGEMENT | 280 | $3,609 | 0.00% |
| FMR LLC | 7 | $90 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 3,711 | $47,835 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6,138 | $79,119 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,465 | $18,884 | 0.00% |
| NORTHERN TRUST CORP | 54,687 | $704,916 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Legal & General Group Plc | 841 | $10,840 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 129,663 | $1,671,499 | 0.00% |
| STATE STREET CORP | 108,122 | $1,393,693 | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 5,772 | $74 | 0.00% |
This page lists NUVECTIS PHARMA INC's shareholders in Q3 2023. To view NUVECTIS PHARMA INC's shareholder history, click here.